Promega is a renowned innovator of reagents and consumables for the life sciences and drug discovery industries, with a solid reputation for expert technical support. With over 2,000 catalogue products, a growing portfolio of custom offerings and OEM solutions, Promega enables scientists and businesses alike to advance their research and their competitiveness.
Working closely with customers, to understand their research efforts and business drivers, Promega brings both knowledge and reagents from both the product portfolio and development pipelines into play. Promega offers access to the latest, market-leading technologies whilst appreciating the need to deliver savings from a cost and time perspective. This approach engenders both a deep relationship and a critical business alignment.
Founded in 1978, with what started as the production of enzymes for molecular biology researchers, Promega has evolved to support a broad array of applications including basic research, drug discovery, forensics and paternity testing, and hospital and clinic-based research. Products, such as cell based assays, specialised biochemicals, chemicals, enzymes, peptides, antibodies and nucleic acids are used primarily by customers to understand the molecular basis of life, potential mechanisms of disease and to identify targets for drug development.
The value of Promega reagents derives from the purity, ease of use, effectiveness, compatibility with other materials or other instruments and the unique physical and chemical characteristics of the reagents.
For example, starting with a single well defined reaction, Promega has developed a solid technology platform from which hundreds of unique in vitro biochemical and cell based assays have been configured to provide solutions enabling the development of better drugs faster.
Focussing predominantly on bioluminescence, Promega’s assays deliver better profiling data, more biologically relevant data and an increased understanding of biology. These form the bedrock of target identification, validation and screening in many pharmaceutical, biotechnology and contract research organisations where the volume of assays can vary from a few per day at small academic laboratories to tens of thousands per day at pharmaceutical and clinical laboratories.
Promega has extensive research and development capabilities, 99% of what Promega sells is developed and manufactured by Promega, which enables the company to respond quickly and flexibly to the needs of customers and to the opportunities with in the pharmaceutical, biotechnology and life science markets.
In 2012 many new technologies and products will be launched, particularly in the field of bioluminescent drug discovery assays. Additionally a brand new, purpose built GMP manufacturing plant is under construction to accommodate the increasing demand for Promega’s GMP quality products from OEM customers, who incorporate them into their own kits and products.
Located in the 400-acre Fitchburg Center for mixed-use community, in Madison, Wisconsin, Promega Corporation provides its employees with an outstanding work environment designed to foster innovation and creativity.
Promega UK Ltd
Southampton Science Park
Tel: Customer Service: 0800 378994
Tel: Technical service: 0800 559900